Medical Center Haaglanden   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Leidschendam Netherlands (1873)

Organization Overview

First Clinical Trial
2006
NCT00362141
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Haaglanden Medical Centre | Medical Center Haaglanden | Medical Centre Haaglanden

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Communicable Diseases (Phase 4)

Disease (Phase 4)

Fistula (Phase 2)

Glioma (Phase 4)

Infections (Phase 4)

Neointima (Phase 2)

Pheochromocytoma (Phase 4)

Rectal Neoplasms (Phase 3)

Seizures (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Status Epilepticus (Phase 2)

Urinary Tract Infections (Phase 4)

Vascular Remodeling (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 16